相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyanide-free environment-friendly alternative to copper electroplating for zinc die-cast alloys
Christine Adelle Rico-Yuson et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein
Yunden Jinsmaa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?
Marco Bisaglia et al.
BIOMOLECULES (2020)
Role of Metabotropic Glutamate Receptors in Neurological Disorders
Rosalia Crupi et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Preparation and characterization of nanosilica copper (II) complexes of amino acids
Junfan Niu et al.
JOURNAL OF HAZARDOUS MATERIALS (2018)
Changes in synaptic AMPA receptor concentration and composition in chronic temporal lobe epilepsy
Daniel L. Egbenya et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2018)
Dopamine Autoxidation Is Controlled by Acidic pH
Nejc Umek et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Mechanism of synergistic DNA damage induced by the hydroquinone metabolite of brominated phenolic environmental pollutants and Cu(II): Formation of DNA-Cu complex and site-specific production of hydroxyl radicals
Bo Shao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells
David S. Goldstein et al.
NEUROCHEMICAL RESEARCH (2017)
In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigra
Guohua Yu et al.
EXPERIMENTAL NEUROLOGY (2015)
Antioxidant activity of dopamine and L-DOPA in lipid micelles and their cooperation with an analogue of α-tocopherol
Katarzyna Jodko-Piorecka et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
Cristian Follmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Ceruloplasmin functional changes in Parkinson's disease-cerebrospinal fluid
Marco Barbariga et al.
MOLECULAR NEURODEGENERATION (2015)
Role of Dopamine Neurons in Reward and Aversion: A Synaptic Plasticity Perspective
Marco Pignatelli et al.
NEURON (2015)
Hsp27 suppresses the Cu2+-induced amyloidogenicity, redox activity and cytotoxicity of α-synuclein by metal ion stripping
Abhishek Asthana et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: Mechanism and kinetics
A. Ninh Pham et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Protective and toxic roles of dopamine in Parkinson's disease
Juan Segura-Aguilar et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in SH-SY5Y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease
Kalpita Banerjee et al.
PARKINSONS DISEASE (2014)
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
Scott Ayton et al.
ANNALS OF NEUROLOGY (2013)
Multi-Copper Oxidases and Human Iron Metabolism
Ganna Vashchenko et al.
NUTRIENTS (2013)
Nigral iron deposition occurs across motor phenotypes of Parkinson's disease
L. Jin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease
Lirong Jin et al.
BRAIN (2011)
Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species
Wendy A. Spencer et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Ceruloplasmin Oxidation, a Feature of Parkinson's Disease CSF, Inhibits Ferroxidase Activity and Promotes Cellular Iron Retention
Stefano Olivieri et al.
JOURNAL OF NEUROSCIENCE (2011)
ROS Initiated Oxidation of Dopamine under Oxidative Stress Conditions in Aqueous and Lipidic Environments
Cristina Iuga et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2011)
Quinoprotein Adducts Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced Toxicity in SH-SY5Y Cells
Na Wang et al.
NEUROCHEMICAL RESEARCH (2011)
Different Mechanisms Between Copper and Iron in Catecholamines-Mediated Oxidative DNA Damage and Disruption of Gene Expression In Vitro
Yoshihiko Nishino et al.
NEUROTOXICITY RESEARCH (2011)
Tyrosinase-Expressing Neuronal Cell Line as in Vitro Model of Parkinson's Disease
Takafumi Hasegawa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Copper in Diseases and Treatments, and Copper-Based Anticancer Strategies
Francesco Tisato et al.
MEDICINAL RESEARCH REVIEWS (2010)
Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease
Kersi J. Bharucha et al.
JOURNAL OF NEUROLOGY (2008)
Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NOx content in the CSF.: A different marker profile in four neurodegenerative diseases
Marie-Catherine Boll et al.
NEUROCHEMICAL RESEARCH (2008)
Regulation of synaptic transmission by ambient extracellular glutamate
David E. Featherstone et al.
NEUROSCIENTIST (2008)
Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin
Ivana De Domenico et al.
EMBO JOURNAL (2007)
Dopamine neuron systems in the brain:: an update
Anders Bjorklund et al.
TRENDS IN NEUROSCIENCES (2007)
Dopamine: 50 years in perspective
Susan D. Iversen et al.
TRENDS IN NEUROSCIENCES (2007)
Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone formation-related molecules
I Miyazaki et al.
FASEB JOURNAL (2006)
Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions
SM Sang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
The role of metabotropic glutamate receptor 5 in learning and memory processes
A Simonyi et al.
DRUG NEWS & PERSPECTIVES (2005)
Inhibition of α-synuclein fibrillization by dopamine analogs via reaction with the amino groups of α-synuclein
HT Li et al.
FEBS JOURNAL (2005)
Molecular pathways of neurodegeneration in Parkinson's disease
TM Dawson et al.
SCIENCE (2003)
3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinson's Disease
W. J. Burke
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics
L Zecca et al.
TRENDS IN NEUROSCIENCES (2003)
The copper-iron connection: Hereditary aceruloplasminemia
T Nittis et al.
SEMINARS IN HEMATOLOGY (2002)
Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s
DI Pattison et al.
TOXICOLOGY (2002)
Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity
J Yuan et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The Roles of Dopamine Oxidative Stress and Dopamine Receptor Signaling in Aging and Age-Related Neurodegeneration
Yongquan Luo et al.
ANTIOXIDANTS & REDOX SIGNALING (2000)
分享论文
